These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28407342)

  • 1. Cardiovascular safety of insulin: Between real-world data and reality.
    Mannucci E; Ferrannini E
    Diabetes Obes Metab; 2017 Sep; 19(9):1201-1204. PubMed ID: 28407342
    [No Abstract]   [Full Text] [Related]  

  • 2. The UK Prospective Diabetes Study.
    Kerner W
    Lancet; 1998 Dec; 352(9144):1934. PubMed ID: 9863811
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular effects of insulin therapy: from pharmacology to clinical trials].
    Mannucci E
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):19S-23. PubMed ID: 27030120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
    Ekström N; Svensson AM; Miftaraj M; Franzén S; Zethelius B; Eliasson B; Gudbjörnsdottir S
    Diabetes Obes Metab; 2016 Oct; 18(10):990-8. PubMed ID: 27282621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of insulin in type 2 diabetes.
    Joshi SR
    J Assoc Physicians India; 2007 Jul; 55 Suppl():41-3. PubMed ID: 17927010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular safety of incretin-based therapy for type 2 diabetes: A meta-analysis of randomized trials.
    Mahmoud AN; Saad M; Mansoor H; Elgendy AY; Barakat AF; Abuzaid A; Mentias A; Elgendy IY
    Int J Cardiol; 2017 Mar; 230():324-326. PubMed ID: 28043676
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin treatment, NIDDM and atherosclerosis.
    Shumak SL
    CMAJ; 1991 Jul; 145(2):134. PubMed ID: 1860104
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin therapy does not itself induce weight gain in patients with type 2 diabetes.
    Larger E; Rufat P; Dubois-Laforgue D; Ledoux S
    Diabetes Care; 2001 Oct; 24(10):1849-50. PubMed ID: 11574460
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin replacement therapy. Minimizing complications and side effects.
    Fleury-Milfort E
    Adv Nurse Pract; 2008 Nov; 16(11):32-9: quiz 39-40. PubMed ID: 19999054
    [No Abstract]   [Full Text] [Related]  

  • 11. Type 2 diabetes: the role of insulin.
    Brunton S; Carmichael B; Funnell M; Lorber D; Rakel R; Rubin R
    J Fam Pract; 2005 May; 54(5):445-52. PubMed ID: 15865903
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular effects of troglitazone.
    Umland EM; Romanelli AM
    Ann Pharmacother; 1999 Feb; 33(2):229-32. PubMed ID: 10084419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin edema in patients with diabetes mellitus and recent diabetic ketoacidosis (epidemiology and case reports)].
    Khalangot ND; Koka MA; Latypova GA; Bakhtiiarova AA
    Lik Sprava; 2004 Dec; (8):39-43. PubMed ID: 15771070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical advances in diabetes].
    Martin S; Scherbaum WA
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1461-2. PubMed ID: 16794976
    [No Abstract]   [Full Text] [Related]  

  • 15. Achieve better glucose control for your hospitalized patients.
    Woolever DR
    J Fam Pract; 2008 Dec; 57(12):782-8. PubMed ID: 19080760
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid improvement of psoriasis in diabetes subsequent to glucose lowering.
    Ogoshi M; Horikawa T
    Int J Dermatol; 2014 Feb; 53(2):e106-7. PubMed ID: 23432425
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin-induced localized lipoatrophy.
    Breznik V; Kokol R; Luzar B; Miljković J
    Acta Dermatovenerol Alp Pannonica Adriat; 2013 Dec; 22(4):83-5. PubMed ID: 24336944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?
    Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
    Diabet Med; 2011 Mar; 28(3):276-86. PubMed ID: 21309835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.
    Jil M; Rajnikant M; Richard D; Iskandar I
    Diab Vasc Dis Res; 2017 Jul; 14(4):295-303. PubMed ID: 28330386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and heart failure: is insulin therapy the answer?
    Levy WC; Hirsch IB
    J Am Coll Cardiol; 2003 Sep; 42(6):1051-3. PubMed ID: 13678929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.